Protagenic Therapeutics, Inc.\new — insider transactions

7 transactions on record · PTIX · CIK 1022899

Aggregates

computed from the filings below
Purchases, 12m
7
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
—
no sales recorded
Distinct insiders, 12m
1
Bought, 3m
$30.7K
Sold, 3m
$0
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$13K
2026-08-21
Director share, 12m
100.0%
of transactions where role is stated
Current run
7 buys
consecutive same-direction transactions
Net 3m flow
$30.7K
purchases minus sales
Total on record
7

Transactions

7 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-242026-08-213ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase20,000$0.65$13Kfiling
2026-08-202026-08-191ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase2,700$0.35$945filing
2026-08-202026-08-200ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase16,634$0.59$9.8Kfiling
2026-08-122026-08-111ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase2,220$0.32$710.4filing
2026-08-102026-08-064ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase685$0.22$150.7filing
2026-08-062026-08-051ARMEN GARO HDirector, PRINCIPAL OFFOpen market purchase5,000$0.26$1.3Kfiling
2026-08-032026-07-304ARMEN GARO HDirector, EXEC. CHAIR & PRINCIPAL OFF.Open market purchase26,291$0.18$4.8Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Protagenic Therapeutics, Inc.\new insider transactions — 7 filings on record — investment.com